Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

NCT01266850 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1384

Enrollment

NIH

Sponsor class

Conditions

Rotavirus Infection

Interventions

BIOLOGICAL: Rotarix®
BIOLOGICAL: RotaTeq®

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)